A knowledge-aware, constraint-guaranteed decoder for cyclic peptides
Authors/Creators
- 1. BioMate AI
- 2. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 3. Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA
Description
Cyclic peptides reach a prized middle ground between small molecules and biologics: large
enough to grip the flat protein–protein interfaces that defeat conventional drugs, yet
sometimes lipophilic enough to be taken as a pill. Deep generative models have transformed
small-molecule and protein design, but cyclic peptides are a harder frontier, with a design
space of non-canonical residues, N-methylation, D-amino acids and macrocyclic rings that is
far too large to search by hand. The models built for it are also hard to evaluate: they are
often scored by distribution metrics, judged by the predictor that trained them, or compared
with untuned baselines at unequal budgets — tests on which a weak method can look strong.
Here we present IH-LM, a cyclic-peptide generator that compiles the design rules directly
into the decoder, so every molecule it completes satisfies them by construction; across a
900-molecule test set it also discarded no rule-satisfying string. The preliminary
experimental results are promising. Benchmarked against tuned baselines at a matched
sampling budget, it produces about three times as many valid, novel molecules as
enumerating a monomer library (773 versus 246 per 1,000 samples) and spans about three
times as many distinct scaffolds for the same effort. Conditioned on measured membrane
permeability, the same decoder steers generation toward more permeable novel macrocycles
— a shift of about half a decade in log-𝑃app, confirmed by an independent cross-source
evaluator and robust across re-runs — so the generator learns from measurement, not only
from its own rollouts. Because validity is guaranteed rather than scored, the full strength of
evaluation can be devoted to the properties that decide a candidate’s fate — chemical
diversity, permeability and, ultimately, target activity — which is where real progress in
cyclic-peptide design will be won.